Your browser doesn't support javascript.
loading
Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria.
Nishimura, Jun-Ichi; Ando, Kiyoshi; Masuko, Masayoshi; Noji, Hideyoshi; Ito, Yoshikazu; Mayer, Jiri; Griskevicius, Laimonas; Bucher, Christoph; Müllershausen, Florian; Gergely, Peter; Rozenberg, Izabela; Schubart, Anna; Chawla, Raghav; Rondeau, Jean-Michel; Roguska, Michael; Splawski, Igor; Keating, Mark T; Johnson, Leslie; Danekula, Rambabu; Bagger, Morten; Watanabe, Yoko; Haraldsson, Börje; Kanakura, Yuzuru.
Afiliación
  • Nishimura JI; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita. junnishi@bldon.med.osaka-u.ac.jp.
  • Ando K; Department of Hematology and Oncology, Tokai University, Isehara.
  • Masuko M; Department of Hematology, Endocrinology and Metabolism, Niigata University Medical and Dental Hospital, Niigata.
  • Noji H; Department of Cardiology and Hematology, Fukushima Medical University, Fukushima.
  • Ito Y; Department of Hematology, Tokyo Medical University, Shinjuku-ku, Tokyo.
  • Mayer J; Department of Internal Medicine, Hematology and Oncology, Masaryk University Hospital and Faculty of Medicine, Brno, Czech Republic.
  • Griskevicius L; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos and Institute of Clinical Medicine, Vilnius University, Vilnius.
  • Bucher C; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Müllershausen F; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Gergely P; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Rozenberg I; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Schubart A; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Chawla R; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Rondeau JM; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Roguska M; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Splawski I; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Keating MT; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Johnson L; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Danekula R; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Bagger M; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Watanabe Y; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Haraldsson B; Novartis Institutes for BioMedical Research, Basel, Switzerland, Cambridge, USA, and Novartis Pharma KK, Toranomon Minato-ku, Tokyo.
  • Kanakura Y; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan; Sumitomo Hospital, Osaka.
Haematologica ; 107(6): 1483-1488, 2022 06 01.
Article en En | MEDLINE | ID: mdl-35263983
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hemoglobinuria Paroxística Límite: Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hemoglobinuria Paroxística Límite: Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article